Results 221 to 230 of about 534,909 (297)
Editorial: Organ transplantation by 2040
Jerzy W. Kupiec-Weglinski +1 more
doaj +1 more source
Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu +6 more
wiley +1 more source
Dueling with the dual artery blood supply in pancreas transplantation: why replace the Y? [PDF]
Fridell JA, Stratta RJ.
europepmc +1 more source
Blood vascular permeability is a hallmark of cancer and acts as an active driver of metastatic dissemination. Metastasis accounts for the vast majority of cancer deaths, yet most work has focussed on tumour‐intrinsic traits and angiogenesis, while the specific contribution of endothelial barrier regulation to intravasation and extravasation remains ...
Pierre Boucher +6 more
wiley +1 more source
Evolving Trends in the Management of Duodenal Leaks After Pancreas Transplantation: A Single-Centre Experience. [PDF]
Ray S +9 more
europepmc +1 more source
Does Everyone Need CEA? A Case for Selective Omission After Colorectal Cancer Resection
ANZ Journal of Surgery, EarlyView.
Matthew P. Irwin +3 more
wiley +1 more source
The gut microbiota metabolite indole ‐ 3 ‐ propionic acid(IPA) enhanced the inhibitory effect of SCB on tumor growth in HCC mice. IPA upregulated IL‐12A expression through facilitating acetylation of H3K27 in DCs. IPA elevated IL‐12A expression in DCs to promote CD8+ T cell anti‐tumor immunity and ultimately enhances the efficacy of SCB therapy against
Rui Zhao +7 more
wiley +1 more source
F3/TF‐high ovarian clear cell carcinoma exhibits an immune‐cold phenotype characterized by reduced immune‐cell fractions and attenuated cancer‐cell interferon programs, with frequent B7‐H4 co‐expression. Patient‐derived models show preclinical sensitivity to the TF‐directed antibody–drug conjugate tisotumab vedotin.
Yutaro Mori +7 more
wiley +1 more source
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series. [PDF]
Masset C +10 more
europepmc +1 more source

